Viewing Study NCT06251934


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-02-04 @ 5:42 AM
Study NCT ID: NCT06251934
Status: COMPLETED
Last Update Posted: 2024-02-09
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic Melanoma
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-09-28
Start Date Type: ACTUAL
Primary Completion Date: 2022-11-01
Primary Completion Date Type: ACTUAL
Completion Date: 2022-11-24
Completion Date Type: ACTUAL
First Submit Date: 2024-02-01
First Submit QC Date: None
Study First Post Date: 2024-02-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-02-01
Last Update Post Date: 2024-02-09
Last Update Post Date Type: ACTUAL